To study DNA-PKcs's effect on TIC10 in the primary HCC cells, siRNA strategy was applied to transitorily knockdown DNA-PKcs in the primary human HCC cells (“Pri_1”). Here, PRKDC is linked to hepatocellular carcinoma.